Return to Results

A multicenter, randomized, double-blind, placebo-controlled study of the effects of KW-3902 Injectable Emulsion on heart failure signs and symptoms, diuresis, renal function, and clinical outcomes in

new search

Trial Conditions
  • Heart failure associated with worsening kidney function
What is the purpose of this trial?

This study will evaluate the effect of KW-3902 (diuretic), in addition to standard therapy, on heart failure symptoms and on kidney function.

Date & Status

Recruiting

Steward Physician(s)
Facilities
  • St. Elizabeth's Medical Center - Recruiting
For more information about this trial, contact

Ann Pieczek
ann.pieczek@steward.org
Phone: 617-789-3043


Physician Researcher

Physician Name/s:

  • James P. Morgan MD
  • Lana  Tsao MD
  • Other Information

    Sponsor: NovaCardia, Inc.
    Phase: Phase 3
    Trial ID: 00409
    Volunteers:  Not Accepting Healthy Volunteers

    new search

    Connect with Steward

    Visit Our Twitter Feed Visit Our Facebook Page Email This Page Print This Page

    Subscribe to our patient e-newsletter

    Copyright © 2014 Steward Health Care
    Connect Healthcare Panacea CMS Solutions